NK:IO

Developer of a biotechnology company designed to advance new methods in natural killer cell-based immunotherapy for cancer treatment. The company develops cell therapies and small molecule drugs that ...

Healthcare

London, United Kingdom

Founded 2020

11 employees

Website

Valuation

$9.2M

Market implied

Share Price

N/A

Total Raised

$6.7M

Last Round

N/A

Investors

+11 other investors

View all 11 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock NK:IO's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required